Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
Chris Parker(Royal Marsden NHS Foundation Trust), David P. Dearnaley(Royal Marsden NHS Foundation Trust)
Cited by 16
Related Papers
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
|British Journal of Cancer|2005|230